Delivering Tamoxifen within Solid Lipid Nanoparticles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Delivering Tamoxifen within Solid Lipid Nanoparticles
The aim of this study was to prepare and characterize physiochemically and biologically tamoxifen-loaded SLNs to evaluate their effectiveness as a drug-delivery system to treat breast cancers.


Pharmaceutical Technology
Volume 35, Issue 4, pp. 74-79

References

1. G. Fontana et al., Drug Deliv. 12 (6), 385–392 (2005).

2. V.C. Jordan, Br. J. Pharmacol. 110 (2), 507–517 (1993).

3. E. Memisoglu-Bilensoy et al., J. Control. Release 104 (3), 489–496 (2005).

4. J.S. Chawla and M.M. Amiji, Int. J. Pharm. 249 (1–2), 127–138 (2002).

5. K. Jores et al., Pharm. Res. 22 (11), 1887–1897 (2005).

6. H. Yuan et al., Colloids Surf. B. Biointerfaces 61 (2), 132–137 (2007).

7. K. Westesen, H. Bunjes, and M.H.J. Koch, J. Control. Release 48 (2–3,), 223–236 (1997).

8. A.Z. Mühlen, C.Schwarz, and W.Mehnert, Eur. J. Pharm. Biopharm. 45 (2), 149–155 (1998).

9. M.A. Schubert and C.C. Müller-Goymann, Eur. J. Pharm. Biopharm. 61 (1–2), 77–86 (2005).

10. R. Lander et al., Biotechnology Progress 16 (1), 80–85 (2000).

11. A.A. Attama and C.C. Müller-Goymann, Int. J. Pharm. 334 (1–2), 179–189 (2007).

12. I. Mountasser, H. Fessi, and A.W. Coleman, Eur. J. Pharm. Biopharm. 54 (3), 281–284 (2002).

13. I. Brigger et al., Int. J. Pharm. 214 (1–2), 37–42 (2001).

14. F. Ikom, G.K. Hanna, and G.W. Schmid-Schmid, Lymphology 32 (3), 90–102 (1999).

15. D.Z. Hou et al., Biomater. 24 (10), 1781–1785 (2003).

16. H.L. Reddy et al., Pharm. Dev. Tech. 11 (2), 167–177 (2006).

17. H.L. Wong et al., J. Pharm. Sci. 93 (8), 1993–2008 (2004).

18. H. Yuan et al., Int. J. Pharm. 348 (1–2), 137–145 (2008).

19. A. Maschke et al., Eur. J. Pharm. Biopharm. 65 (2), 175–187 (2007).

20. S.A. Wissing, O. Kayser, and R.H. Müller, Adv. Drug Deliv. Rev. 56 (9), 1257–1272 (2004).

21. L. Serpe et al., Anticancer Drug 15 (5), 525–536 (2004).

Citation: When referring to this article, please cite it as "R.Abbasalipourkabir, .Salehzadeh, R.Abdullah, "Delivering Tamoxifen Within Solid Lipid Nanoparticles,"Pharmaceutical Technology 35 (4) 74-80 (2011)."


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here